Kinney Horn's most recent trade in Immunome Inc was a trade of 1,092 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on July 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2026 | 1,092 | 128,908 | - | - | Employee Stock Option (right to buy) | |
| Immunome Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 07 Jul 2026 | 1,092 | 0 | - | 25 | 27,300 | Common Stock |
| Immunome Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.92 per share. | 07 Jul 2026 | 1,092 | 1,092 | - | 12.9 | 14,109 | Common Stock |
| Immunome Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 161,000 | 161,000 | - | - | Employee Stock Option (right to buy) | |
| Immunome Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 130,000 | 130,000 | - | - | Stock option (right to buy) | |
| Immunome Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 300,000 | 300,000 | - | - | Stock option (right to buy) | |
| Olema Pharma Inc | Kinney Horn | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 4.75 per share. | 10 Mar 2022 | 5,253 | 2,458 | - | 4.8 | 24,952 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2022 | 5,253 | 141,785 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Mar 2022 | 5,253 | 7,711 | - | 2.1 | 10,842 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 5,251 | 147,038 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Feb 2022 | 5,251 | 7,709 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Feb 2022 | 5,251 | 2,458 | - | - | Common Stock | |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 133,000 | 133,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 10 Jan 2022 | 5,251 | 2,458 | - | 6.8 | 35,969 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2022 | 5,251 | 152,289 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Jan 2022 | 5,251 | 7,709 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Dec 2021 | 5,251 | 7,709 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2021 | 5,251 | 157,540 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 10.39 per share. | 10 Dec 2021 | 5,251 | 2,458 | - | 10.4 | 54,558 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 26.88 per share. | 10 Nov 2021 | 27,668 | 1,790 | - | 26.9 | 743,716 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.00 per share. | 10 Nov 2021 | 22,417 | 29,458 | - | 19 | 425,923 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2021 | 22,417 | 67,253 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2021 | 5,251 | 162,791 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Nov 2021 | 5,251 | 7,041 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2021 | 5,251 | 168,042 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 11 Oct 2021 | 5,251 | 7,041 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 28.19 per share. | 11 Oct 2021 | 3,146 | 1,790 | - | 28.2 | 88,686 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 27.47 per share. | 11 Oct 2021 | 2,105 | 4,936 | - | 27.5 | 57,824 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 29.38 per share. | 10 Sep 2021 | 5,251 | 1,790 | - | 29.4 | 154,274 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2021 | 5,251 | 173,293 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Sep 2021 | 5,251 | 7,041 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 5,251 | 178,544 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Aug 2021 | 5,251 | 7,041 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 25.70 per share. | 10 Aug 2021 | 5,191 | 1,850 | - | 25.7 | 133,409 | Common Stock |
| Olema Pharma Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 26.17 per share. | 10 Aug 2021 | 60 | 1,790 | - | 26.2 | 1,570 | Common Stock |